Dr. Roger Greenwood
Lister Hospital, Stevenage

Following a first career in aeronautical engineering Roger Greenwood graduated in medicine from Bristol, UK, in 1976. After training in Manchester and London (Barts) he moved to Stevenage in 1988 to establish a new renal unit (Lister) where he then was Clinical Director of Renal Services for 20 years. He continues as Consultant Nephrologist in the NHS.

His main areas of interest in clinical research and service development include haemodiafiltration (HDF), self-care and home haemodialysis, non-dialytic conservative management and end-of-life issues.

Dr. Greenwood was President of the British Renal Society (1997-2000), Chairman of the Kidney Alliance (2003-2007) and a member of the External Reference Group of the Renal National Service Framework (2001-2004). He is currently a member of the national Clinical Reference Group (dialysis) advising NHS England on the transition of Specialised Services Commissioning into new NHS structures. He also is a member of the East of England Clinical Senate Assembly which provides clinical advice and strategic leadership to the local health economy.

Dr. Roger Greenwood, Quanta Dialysis Technologies, Self Care+, SC+, The Lister Hospital Stevenage, Consultant Nephrologist

Dr. Clara Day

Clara Day is a Consultant Nephrologist at the Queen Elizabeth Hospital in Birmingham (QEHB).

After graduating from the University of Oxford in 1995, Dr. Day trained as nephrologist within the West Midlands and, was awarded a PhD in renal immunology from the University of Birmingham in 2007. She was appointed to her Consultant post in 2008.

Dr. Day leads the 950-patient chronic haemodialysis programme at QEHB, which is spread across a central unit and 10 satellite units. She has a particular focus on organisational change, governance, patient engagement and peer support. Dr. Day is a committed home haemodialysis enthusiast and has led the rapid expansion of the programme to a current level of 55 patients. Her other areas of renal specialisation include pregnancy in renal disease, co-leading a regional renal obstetric service, and lupus nephritis. Her current main research interests are focussed around quality of life in dialysis patients with a particular focus on depression and she is a member of the British Renal Society research committee.

Quanta Dialysis Technologies, Self Care+, SC+, Dr Clara Day, University Hospital Birmingham, UHB, Nephrologist

Prof. John Agar

Prof. Agar, a practicing clinical nephrologist, is currently Clinical Conjoint Professor of Medicine at Deakin University School of Medicine and the Geelong Hospital, Barwon Health.

Until 2011, he was the Director of Nephrology (1978-2011) and Chief of Service Medicine (1995-2005) at Barwon Health in Geelong, Australia. He is a renowned nocturnal home haemodialysis specialist and sits on the Clinical Advisory Boards of Renal Solutions Inc. (USA) and Fresenius Medical Care (Aust.) and is an advisor to Baxter Healthcare. John was senior transplant physician to the Transplant Service at St. Vincent’s Hospital, Melbourne (1991-2013), and is a Clinical Associate Professor of Medicine at the University of Melbourne. More than 40% of the dialysis patient population at the Geelong service dialyse at home (HD or PD), with 25% of all haemodialysis patients using nocturnal home haemodialysis.

Prof. Agar has been widely published in peer-reviewed literature on the medical and economic benefits of nocturnal home haemodialysis and has been a recognized leader in the expansion of this innovative therapy in Australia. Recognizing the need for resource conservation and for more thoughtful environmental dialysis practices, he has led the creation of a green dialysis literature base for the specialty and has also been published widely in this field.

John Agar, Geelong Hospital, Prof. Agar, Prof Agar

Tony Goovaerts
Cliniques Universitaires Saint-Luc, Bruxelles

Tony Goovaerts is a Certified Nephrology Nurse with managing qualification and 36 years experience in the field.

He is the nurse manager of the Home Hemodialysis, PD and Pre-treatment Counselling Programmes, and of a self-care hemodialysis satellite unit of the University Hospital St Luc in Brussels, Belgium.

Tony was, for many years, a Committee member of the EDTNA/ERCA (European Dialysis and Transplant Nurses Association/European Renal Care Association). He was a co-founder of the World Foundation for Renal Care and its Vice-President from 1996 to 2002 and remains an international adviser for the Foundation.

Tony Goovaerts, University Hospital St Luc, EDTNA/ERCA

Dr. Nicholas Hoenich

Dr. Nicholas Hoenich is a member of the Institute of Cellular Medicine at Newcastle University and a visiting lecturer at Bradford University, where he contributes to the Medical and Healthcare Technology programme. His expertise and knowledge of haemodialysis is recognised at the very highest level as a member of the expert advisory group to the Medicines and Healthcare Products Regulatory Agency (MHRA) and as Convenor for the International Standards Organisation (ISO) Technical Committee, dealing with Renal Replacement, Detoxification and Apheresis.  Dr. Hoenich is also a member of the International Electrotechnical Commission (IEC) subcommittee tasked with the development of standards and technical reports for electrical equipment used in medical practice and a member of editorial boards for several journals on artificial organs. Dr. Hoenich has been the author of numerous publications on technologies used in the replacement of renal function and was also a former President of the Association of Renal Technologists.

Dr. Nicholas Hoenich

Dr. Elizabeth Lindley

Leeds Teaching Hospitals NHS Trust

Dr. Elizabeth Lindley is a Specialist Clinical Scientist working in the Department of Renal Medicine at the Leeds Teaching Hospitals NHS Trust. She is Co-Lead for the Renal Theme of the NIHR Devices for Dignity Healthcare Technology Co-operative and a facilitator for the UK Renal Technology course in Bradford.

Although Lizzi originally trained as a solid state physicist at the Institute Laue-Langevin in Grenoble, she moved to cancer research soon after completing her PhD and then to renal care in 1989.

Lizzi is currently moderator of the RenalPro e-mail discussion forum for renal care professionals, and a member of the European Renal Association’s Best Practice Advisory Board (ERBP) and the UK Renal Association’s Clinical Practice Guidelines committee.

Dr. Elizabeth Lindley

Dr. Peter Kerr

Dr. Peter Kerr is Professor and Director of Nephrology at Monash Medical Centre and Monash University, Victoria, Australia. He completed his undergraduate in medicine at Monash University in 1980 and completed his Nephrology training in Melbourne where he then went on to complete a laboratory PhD in transplant immunology before moving onto haemodialysis. Dr Kerr went onto complete a  year studying Haemodialysis in Montpellier, France where he has since been involved in registries (ANZDATA and DOPPS), basic and clinical research and remains an active clinician in charge of a large multi-faceted Nephrology Unit. He is a strong advocate for home-based dialysis therapies and is committed to building and sustaining Nephrology in the Asian-Pacific region. In addition to this, Dr Kerr is also Editor-in-Chief of the Asian-Pacific Journal of Nephrology since 2010.

Peter Kerr